Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States (revised November 3, 2000).

出版信息

HIV Clin Trials. 2001 Jan-Feb;2(1):56-91. doi: 10.1310/3ENW-TR0F-UQ0B-GWKD.

Abstract

摘要

相似文献

[1]

Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States (revised November 3, 2000).

HIV Clin Trials. 2001

[2]

US Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States, February 25, 2000.

HIV Clin Trials. 2000

[3]

Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. Centers for Disease Control and Prevention.

MMWR Recomm Rep. 1998-1-30

[4]

U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.

MMWR Recomm Rep. 2002-11-22

[5]

Antiretroviral treatments to reduce mother-to-child transmission of HIV.

HIV Clin Trials. 2001

[6]

Prevention of perinatal HIV infection: cause for optimism.

AIDS Clin Care. 1999-12

[7]

Perinatal guidelines for use of antiretroviral drugs updated.

AIDS Read. 2000-4

[8]

Antiretroviral drugs to prevent breastfeeding HIV transmission.

Antivir Ther. 2010

[9]

Antiretroviral therapy in HIV-infected pregnant women and their infants: current interventions and challenges.

J Perinat Neonatal Nurs. 2002-9

[10]

A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.

J Infect Dis. 2003-3-1

引用本文的文献

[1]

Challenges for Obstetricians and the Countermeasures of COVID-19 Epidemic.

Matern Fetal Med. 2020-3-13

[2]

Why are Children Still Being Infected with HIV? Impact of an Integrated Public Health and Clinical Practice Intervention on Mother-to-Child HIV Transmission in Las Vegas, Nevada, 2007-2012.

Ann Med Health Sci Res. 2015

[3]

A review of missed opportunities for prenatal HIV screening in a nationwide sample of health facilities in the Indian Health Service.

J Community Health. 2011-8

[4]

Increasing use of rapid HIV testing in labor and delivery among women with no prenatal care: a local initiative.

Matern Child Health J. 2011-8

[5]

Perinatal HIV transmission and the cost-effectiveness of screening at 14 weeks gestation, at the onset of labour and the rapid testing of infants.

BMC Infect Dis. 2008-12-31

[6]

Determinants of HIV shedding in the lower genital tract of women.

Curr Infect Dis Rep. 2008-11

[7]

Women identified with HIV at labor and delivery: testing, disclosing and linking to care challenges.

Matern Child Health J. 2008-9

[8]

Teratogenicity risk of antiretroviral therapy in pregnancy.

Curr HIV/AIDS Rep. 2007-8

[9]

Should antiretroviral therapy be started earlier?

Curr HIV/AIDS Rep. 2007-5

[10]

Effect of antiretroviral agents on triglyceride levels in HIV-1-infected pregnant women.

Lipids. 2006-4

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

新学期，新优惠

Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States (revised November 3, 2000).

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

推荐工具

Suppr 超能文献

相似文献

引用本文的文献